文献速递神经肿瘤

[18F]氟多巴正电子发射断层显像在胶质瘤分级中的作用

The role of [18F]fluorodopa positron emission tomography in grading of gliomas.
PubMed 文献 · J Neurooncol · 2022-11-24

本综述讨论18F-FDOPA-PET在新诊断胶质瘤中区分低级别与高级别的文献;2016年RANO与EANO已发布胶质瘤PET临床使用推荐,此后有多项研究探讨18F-FDOPA-PET能否在标准MRI典型转化影像出现前识别高级别转化区域;结论认为需要更大规模研究验证其作为胶质瘤分级及预测肿瘤分子特征的无创标志物。

要点

  • 18F-FDOPA-PET用于新诊断胶质瘤区分低级别与高级别。
  • 2016年RANO与EANO发布胶质瘤PET临床使用推荐。
  • 需更大规模研究验证其分级与预测分子特征的价值。

核心结论

  • 需要更大规模研究验证18F-FDOPA-PET作为胶质瘤分级及预测肿瘤分子特征的无创标志物,以指导手术切除决策。

研究设计与样本

  • 综述,讨论18F-FDOPA-PET在新诊断胶质瘤中区分低级别与高级别的现有文献。

主要发现

  • 2016年RANO与EANO发布了胶质瘤PET显像临床使用推荐。
  • 此后有多项研究探讨18F-FDOPA-PET能否在标准MRI典型转化影像特征如对比增强出现前识别高级别转化区域。

局限性

  • 原文结论提出需要更大规模研究验证18F-FDOPA-PET作为胶质瘤分级及预测肿瘤分子特征的无创标志物。

以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。

原文

PURPOSE: Gliomas are the most commonly occurring brain tumour in adults and there remains no cure for these tumours with treatment strategies being based on tumour grade. All treatment options aim to prolong survival, maintain quality of life and slow the inevitable progression from low-grade to high-grade. Despite imaging advancements, the only reliable method to grade a glioma is to perform a biopsy, and even this is fraught with errors associated with under grading. Positron emission tomography (PET) imaging with amino acid tracers such as [18F]fluorodopa (18F-FDOPA), [11C]methionine (11C-MET), [18F]fluoroethyltyrosine (18F-FET), and 18F-FDOPA are being increasingly used in the diagnosis and management of gliomas. METHODS: In this review we discuss the literature available on the ability of 18F-FDOPA-PET to distinguish low- from high-grade in newly diagnosed gliomas. RESULTS: In 2016 the Response Assessment in Neuro-Oncology (RANO) and European Association for Neuro-Oncology (EANO) published recommendations on the clinical use of PET imaging in gliomas. However, since these recommendations there have been a number of studies performed looking at whether 18F-FDOPA-PET can identify areas of high-grade transformation before the typical radiological features of transformation such as contrast enhancement are visible on standard magnetic resonance imaging (MRI). CONCLUSION: Larger studies are needed to validate 18F-FDOPA-PET as a non-invasive marker of glioma grade and prediction of tumour molecular characteristics which could guide decisions surrounding surgical resection.

来源:J Neurooncol,查看原文。版权归原作者所有。

引用

  1. Roach JR, Plaha P, McGowan DR, et al. The role of [18F]fluorodopa positron emission tomography in grading of gliomas. J Neurooncol. 2022. PMID: 36434486. doi:10.1007/s11060-022-04177-3

供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。